Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease?

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 8, 1998, Pages 909-922

  Dammeier, Johanna ^a   Brauchle, Maria ^a   Falk, Werner ^b   Grotendorst, Gary R ^c   Werner, Sabine ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Connective tissue growth factor; Crohn's disease; Fibrosis; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; GROWTH FACTOR; INTEGRIN; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ANIMALS; FIBROSIS; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; IMMEDIATE-EARLY PROTEINS; INFLAMMATORY BOWEL DISEASES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINAL MUCOSA; INTESTINES; RABBITS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032146403     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00046-6     Document Type: Article

References (37)

1. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 325:1991;928-937.
2. Gibson P.R., Pavli P. Pathogenic factors in inflammatory bowel disease. Dig. Dis. 10:1992;17-28.
3. R.M. Glickman, Inflammatory bowel disease, in: Harrison's Principles of Internal Medicine, 13th Ed., McGraw Hill, 1994, pp. 1403-1417.
4. E. Rubin and J.L. Farber, Inflammatory bowel disease, in: E. Rubin and J.L. Farber (eds.), Pathology, JB Lippincott, Philadelphia, 1994, pp. 675-683.
5. Kam L., Pizarro T.T., Cominelli F. Cytokines and chemokines in inflammatory bowel disease. Curr. Opin. Gastroenterol. 11:1995;305-309.
6. Brauchle M., Madlener M., Wagner A.D., Angermeyer K., Lauer U., Hofschneider P.H., Gregor M., Werner S. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am. J. Pathol. 149:1996;521-529.
7. Hübner G., Brauchle M., Gregor M., Werner S. Activin A: A novel player and inflammatory marker in inflammatory bowel disease? Lab. Invest. 77:1997;311-318.
8. Igarashi A., Nashiro K., Kikuchi K., Sato S., Ihn H., Fujimoto M., Grotendorst G.R., Takehara K. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J. Invest. Dermatol. 106:1996;729-733.
9. Bradham D.M., Igarashi A., Potter R.L., Grotendorst G.R. Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114:1991;1285-1294.
10. Ryseck R.P., Macdonald-Bravo H., Mattei M.G., Bravo R. Structure, mapping and expression of fisp-12, a growth factor-inducible gene encoding a secreted cystein-rich protein. Cell. Growth. Diff. 2:1991;225-233.
11. O'Brian T.P., Yang G.P., Sanders L., Lau L.F. Expression of Cyr61, a growth factor-inducible immediate early gene. Mol. Cell. Biol. 4:1990;637-645.
12. Simmons D.L., Levy D.B., Yannoni Y., Erikson R.L. Identification of a phorbol ester-repressible v-src-inducible gene. Proc. Natl. Acad. Sci. USA. 86:1989;1178-1182.
13. Joliot V., Martinerie C., Dambrine G., Plassiart G., Brisac M., Crochet J., Perbal B. Proviral rearrangements and overexpression of a new cellular gene (nov) in myoblastosis-associated virus type 1-induced nephroblastomas. Mol. Cell. Biol. 12:1992;10-21.
14. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell. 4:1993;637-645.
15. Grotendorst G.R., Okochi H., Hayashi N. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell. Growth Diff. 7:1996;469-480.
16. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 107:1996;404-411.
17. Kothapalli D., Frazier K.S., Welpy A., Segarini P.R., Grotendorst G.R. Transforming growth factor β induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell. Growth. Diff. 8:1997;61-68.
18. Oemar B.S., Werner A., Garnier J.M., Do D.D., Godoy N., Nauck M., Marz W., Rupp J., Pech M., Luscher T.F. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 95:1997;831-839.
19. Frazier K.S., Grotendorst G.R. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int. J. Cell Biol. 29:1997;153-161.
20. Martin P. Wound healing - aiming for perfect skin regeneration. Science. 276:1997;75-81.
21. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
22. Werner S., Peters K.G., Longaker M.T., Fuller-Pace F., Banda M.J., Williams L.T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. USA. 89:1992;6896-6900.
23. Derynck R., Jarrett J.A., Chen E., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Sporn M.B., Goeddel D.V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
24. Bernard M.P., Kolbe M., Weil D., Chu M.L. Human cellular fibronectin: comparison of the carboxyterminal portion with rat identifies primary structural domains separated by hypervariable regions. Biochemistry. 24:1985;2698-2704.
25. Rossouw C.M., Vergeer W.P., du Plooy S.J., Bernard M.P., Ramirez F., de Wet W.J. DNA-sequences in the first intron of the human pro-alpha 1 (I) collagen gene enhance transcription. J. Biol. Chem. 262:1987;15151-15157.
26. Auron P.E., Webb A.C., Rosenwasser L.J., Mucci S.F., Rich A., Wolff S.M., Dinarello C.A. Nucleotide sequence of human interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. USA. 81:1984;7907-7911.
27. Rosenthal A., Chan S., Henzel W.M., Haskell C., Kuang W.-J., Chen E., Wilcox J., Ullrich A., Goeddel D. Primary structure and mRNA localization of protein F1, a growth-related protein kinase C substrate associated with synaptic plasticity. EMBO J. 12:1987;3641-3646.
28. Ligumsky A., Simon P.L., Karmeli G., Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease: enhanced production during active disease. Gut. 31:1990;686-689.
29. Nakamura M., Saito H., Kasanuki J., Tamura Y., Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut. 33:1992;933-937.
30. Isaacs K.L., Sartor R.B., Haskin S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterol. 103:1992;1587-1595.
31. McCabe R.P., Secrist H., Botney M., Egan M., Peters M.G. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin. Immunol. Immunpathol. 66:1993;52-58.
32. Stallmach A., Schuppan D., Riese H.H., Matthes H., Riecken E.O. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterol. 102:1992;1920-1929.
33. Matthes H., Herbst H., Schuppan D., Stallmach A., Milani S., Stein H., Riecken E.O. Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterol. 102:1992;431-442.
34. Matthes H., Stallmach A., Matthes B., Herbst H., Schuppan D., Riecken E.O. Hinweise für einen differenten Kollagenmetabolismus bei Morbus Crohn und Colitis ulcerosa. Medizinische Klinik. 88:1993;185-192.
35. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., Sporn M.B. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258:1983;7155-7160.
36. Franklin T.J. Therapeutic approaches to organ fibrosis. Int. J. Biochem. Cell Biol. 29:1997;79-89.
37. Grotendorst G.R. Identification and development of novel antifibrotic agents. Exp. Opin. Invest. Drugs. 6:1997;777-781.